Stellar Biotechnologies announced that third-party trial results have demonstrated that the company’s KLH manufacturing methods achieve robust viral clearance. This clearance step is a key quality assurance milestone under Stellar’s initiatives to increase the scalability and throughput capacity of its manufacturing processes.  Results from testing completed by Texcell, a contract testing organization for viral safety, demonstrated that Stellar’s manufacturing process for...